With funding from the Discovery to Product program, Professor Seungpyo Hong and his collaborators are accelerating their research on idiopathic pulmonary fibrosis.
Pharmaceutical Sciences
2021 Five of the Future
Meet recent UW–Madison School of Pharmacy alumni who are leading their fields forward.
New Assistant Professor Advances Toxicology Research and Education
In a joint role, Heather Barkholtz joins the School of Pharmacy’s Pharmaceutical Sciences Division and the Wisconsin State Laboratory of Hygiene.
Advanced Polymeric Nanotechnology for Delivering Combination Cancer Therapies
Professor Glen Kwon receives a new grant from the National Institutes of Health for research targeting triple-negative breast cancer.
Gel Loaded with Cancer-Fighting Cells Keeps Tumors in Check After Surgery in Mice
A new, biodegradable gel, created by Assistant Professor Quanyin Hu, filled with a cocktail of immune-boosting cytokines and cancer-fighting cells staved off the growth of lingering cancer cells in mice after tumors were surgically removed.
New Method Targets Disease-Causing Proteins for Destruction
Tang Lab at the School of Pharmacy develops new technique for targeted protein degradation By Eric Hamilton This article originally appeared on UW–Madison’s news page. Scientists at the University of Wisconsin–Madison have developed a way …
Professor Ron Burnette Retires from the School of Pharmacy
Professor Ron Burnette has spent nearly 40 years researching, leading, and teaching at the School of Pharmacy.
Measuring the Pancreas’s Protein Landscape Assists Diabetes and Cancer Research
Li Research Group and collaborators publish in Nature Communications on how the pancreas significantly remodels its proteins throughout childhood and stabilizes in adults By Eric Hamilton This article originally appeared on UW–Madison’s news page. The pancreas …
New Potential Drug to Treat Fibrosis
Researchers in the School of Pharmacy’s Kwon Lab have been awarded a patent for a promising new therapy with implications for many conditions, such as kidney disease, heart failure, and even COVID-19.
A New Way to Target Drug-Resistant Breast Cancer
In collaboration with oncology professor Wei Xu, professors Lingjun Li and Weiping Tang are developing tools to tackle breast cancers that no longer respond to traditional therapies.